$OMER Narsoplimab, an inhibitor of mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the lectin pathway of complement and ACTIVATOR of the COAGULATION CASCADE. Isn't that a new wording from Omeros et all? More and more focus on Lectin-Pathways part in coagulation(HSCT-TMA, Covid-19-TMA, ahus-TMAs ect. tct.confex.com/tct/2021/mee...
Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)via: TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR